Key result
A smartphone mechanocardiography-based multiclass classifier using built-in inertial sensors discriminated between normal sinus rhythm, atrial fibrillation, coronary artery disease, and STEMI with an overall accuracy of 75.2%.
Why the study?
Does smartphone mechanocardiography accurately detect and classify cardiovascular conditions such as AFib, CAD, and STEMI?
Cross-Sectional (n=105)
No
Does smartphone mechanocardiography accurately detect and classify cardiovascular conditions such as AFib, CAD, and STEMI?
Smartphone mechanocardiography using built-in inertial sensors combined with machine learning can accurately detect and classify cardiovascular conditions like AFib.
Should not yet change practice; leaves open validation of smartphone mechanocardiography in larger prospective studies.
Cardiac translational and rotational vibrations induced by left ventricular motions are measurable using joint seismocardiography (SCG) and gyrocardiography (GCG) techniques. Multi-dimensional non-invasive monitoring of the heart reveals relative information of cardiac wall motion. A single inertial measurement unit (IMU) allows capturing cardiac vibrations in sufficient details and enables us to perform patient screening for various heart conditions. We envision smartphone mechanocardiography (MCG) for the use of e-health or telemonitoring, which uses a multi-class classifier to detect various types of cardiovascular diseases (CVD) using only smartphone's built-in internal sensors data. Such smartphone App/solution could be used by either a healthcare professional and/or the patient him/herself to take recordings from their heart. We suggest that smartphone could be used to separate heart conditions such as normal sinus rhythm (SR), atrial fibrillation (AFib), coronary artery disease (CAD), and possibly ST-segment elevated myocardial infarction (STEMI) in multiclass settings. An application could run the disease screening and immediately inform the user about the results. Widespread availability of IMUs within smartphones could enable the screening of patients globally in the future, however, we also discuss the possible challenges raised by the utilization of such self-monitoring systems.
No takes yet. Share an insight, caveat, or question.
Iftikhar et al. (2018) conducted a cross-sectional in Cardiovascular diseases (Atrial Fibrillation, Coronary Artery Disease, STEMI) (n=105). Smartphone mechanocardiography (SCG and GCG) vs. Clinical diagnosis and 12-lead ECG (reference standard) was evaluated on Overall diagnostic accuracy of the 4-class machine learning classifier (Normal, AFib, Pre-PCI, STEMI) with majority voting. A smartphone mechanocardiography-based multiclass classifier using built-in inertial sensors discriminated between normal sinus rhythm, atrial fibrillation, coronary artery disease, and STEMI with an overall accuracy of 75.2%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: